Related Experiment Video
Updated: Apr 20, 2026

An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma
Published on: November 15, 2024
Stereotactic laser ablation of high-grade gliomas
Ammar H Hawasli1, Albert H Kim, Gavin P Dunn
1Departments of Neurosurgery.
Abstract:
Evolving research has demonstrated that surgical cytoreduction of a high-grade glial neoplasm is an important factor in improving the prognosis of these difficult tumors. Recent advances in intraoperative imaging have spurred the use of stereotactic laser ablation (laser interstitial thermal therapy [LITT]) for intracranial lesions. Among other targets, laser ablation has been used in the focal treatment of high-grade gliomas (HGGs). The revived application of laser ablation for gliomas parallels major advancements in intraoperative adjuvants and groundbreaking molecular advances in neuro-oncology. The authors review the research on stereotactic LITT for the treatment of HGGs and provide a potential management algorithm for HGGs that incorporates LITT in clinical practice.
Insights
Stereotactic laser interstitial thermal therapy (LITT) offers a focal treatment for high-grade gliomas (HGGs). This review explores LITT
Area of Science:
- Neurosurgery
- Oncology
- Medical Technology
Background:
- Surgical cytoreduction is crucial for improving prognosis in high-grade glial neoplasms.
- Advances in intraoperative imaging enable precise interventions for intracranial lesions.
- High-grade gliomas (HGGs) remain challenging tumors with significant unmet needs.
Purpose of the Study:
- To review the current research on stereotactic laser interstitial thermal therapy (LITT) for HGG treatment.
- To explore the integration of LITT into clinical practice for managing HGGs.
- To propose a management algorithm incorporating LITT for HGGs.
Main Methods:
- Comprehensive literature review of studies utilizing stereotactic LITT for high-grade gliomas.
- Analysis of technological advancements in intraoperative imaging and neuro-oncology.
- Synthesis of research findings to inform a clinical management strategy.
Main Results:
- Stereotactic LITT is emerging as a viable focal treatment option for HGGs.
- The application of LITT is supported by progress in adjuvant therapies and molecular understanding of gliomas.
- LITT complements existing treatment modalities for HGGs.
Conclusions:
- Stereotactic LITT represents a significant advancement in the focal treatment of high-grade gliomas.
- A proposed management algorithm can guide the incorporation of LITT into HGG treatment paradigms.
- Further research and clinical integration of LITT hold promise for improving HGG patient outcomes.
More Related Videos
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
10:52Stereotactic Intracranial Implantation and In vivo Bioluminescent Imaging of Tumor Xenografts in a Mouse Model System of Glioblastoma Multiforme
Published on: September 25, 2012